NCT06440239View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability and Efficacy in Patients With Burn(s)

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
BurnsBurn Degree Second
Interventions
DRUG

PMS-101

PMS-101

OTHER

Standard treatment

Standard treatment according to physicians

Trial Locations (1)

2139

The Concord Repatriation General Hospital, Sydney

Sponsors
All Listed Sponsors
lead

Primoris Therapeutics

INDUSTRY